Cargando…
Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate
In previously performed animal studies and Phase I–II human trials, Bowman-Birk inhibitor concentrate (BBIC) appeared to be a promising cancer chemopreventive agent. The present study describes the results of two phase I randomized double-blind placebo-controlled trials performed in male subjects to...
Autores principales: | LIN, LILIE L., MICK, ROSEMARIE, WARE, JEFFREY, METZ, JAMES, LUSTIG, ROBERT, VAPIWALA, NEHA, RENGAN, RAMESH, KENNEDY, ANN R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961219/ https://www.ncbi.nlm.nih.gov/pubmed/24944684 http://dx.doi.org/10.3892/ol.2014.1855 |
Ejemplares similares
-
Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages
por: Li, Jieliang, et al.
Publicado: (2011) -
Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019) -
Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea
por: Zhang, Luyao, et al.
Publicado: (2018)